Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Taste 2 receptor member 64, pseudogene (TAS2R64P) is classified as a bitter taste receptor gene in the extended TAS2R family. Unlike typical bitter taste receptors, TAS2R64P is annotated as a pseudogene in humans and does not produce a functional receptor protein due to genetic interruptions (such as frameshift mutations or premature stop codons). Bitter taste receptors of the TAS2R family normally serve as G protein-coupled receptors mediating detection of bitter compounds, thus aiding in the avoidance of potentially harmful substances. However, TAS2R64P (as with other TAS2R pseudogenes) has lost its ability to encode a responsive receptor, and there is no evidence that this pseudogene binds bitter compounds or participates in taste signaling. As such, it is not considered a therapeutic target, does not interact with drugs, is not used as a biomarker, and holds no known disease relevance. The gene is sometimes confused with functional family members, so careful distinction is warranted.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taste 2 receptor member 64, pseudogene (TAS2R64P).